Kineta
company
About
Kineta aims at developing edge therapeutics in autoimmune disease, viral disease, and chronic pain areas.
- Seattle,Washington,United States
- 1 - 10
- http://www.kinetabio.com
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $1.50M
- Industries
- Biotechnology,Medical Device,Therapeutics
- Founded date
- Jan 1, 2008
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Stock Symbol
- nasdaq:KA
- Legal Name
- Kineta, Inc.
- Also Known As
- Kineta One LLC
Kineta is a biotechnology company engaging in the discovery and development of antiviral therapies and immune-modulating drugs for the treatment of RNA viruses that include hepatitis C, influenza, West Nile virus, and the common cold.Kineta was founded in 2008 and is based in Seattle, Washington.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
20
$83.22M
Kineta has raised a total of
$83.22M
in funding over 2 rounds. Their latest funding was raised on
Dec 28, 2022 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 28, 2022 | Series Unknown | $7.50M | — | — | — | Detail |
| Dec 19, 2022 | IPO | — | — | — | — | Detail |
| Jun 1, 2021 | Corporate Round | $17.39M | 1 |
Cheongbo Industrial Co. (CBI)
|
— | Detail |
| May 5, 2020 | Series Unknown | $5M | 1 |
SCHLAEPFER FAMILY FOUNDATION
|
— | Detail |
| Aug 6, 2019 | Grant | $1.80M | 1 |
Wellcome Trust
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
5
10
Kineta is funded by 10 investors.
Cheongbo Industrial Co. (CBI)
and SCHLAEPFER FAMILY FOUNDATION
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Cheongbo Industrial Co. (CBI)
|
Yes | Corporate Round |
|
SCHLAEPFER FAMILY FOUNDATION
|
Yes | Series Unknown |
|
Wellcome Trust
|
Yes | Grant |
SFC Capital
|
Yes | Series Unknown |
Keiretsu Capital
|
Yes | Series B |
Keiretsu Forum
|
— | Series Unknown |
National Institute of Allergy and Infectious Diseases
|
— | Grant |
Keiretsu Forum Northwest
|
— | Series Unknown |
AngelMD
|
— | Funding Round |
RJ Jones
|
— | Series Unknown |
Employee Profiles
Number of Employee Profiles
9
Kineta has 9 current employee profiles, including
Executive Charles Magness
Executive
Executive
Executive
Executive
Executive
Acquisition
Kineta has acquired 1 organizations. Their most recent acquisition was Kineta (Reverse Merger With Yumanity Therapeutics) on Dec 19, 2022. They acquired Kineta (Reverse Merger With Yumanity Therapeutics) for 0.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Dec 19, 2022
Kineta (Reverse Merger With Yumanity Therapeutics)
|
Biotechnology | merge | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
